Ozanimod
Ozanimod (RPC-1063) is an orally administered, selective sphingosine-1-phosphate receptor 1 (S1PR1) modulator. It is widely used in preclinical and clinical research for immune-mediated conditions, including investigations into multiple sclerosis and inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.
Product Specifications
CAS Number
1306760-87-1
Product Name Alternative
Neurosurgery, Ozanimod, Lysophospholipid Receptor, LPL Receptor, LPLReceptor, LPL, inhibit, multiple sclerosis (MS), Inhibitor, RPC1063, RPC-1063, RPC 1063, S1P1, S1PReceptor, S1P5, S1P receptor subtypes 1 (S1P1), S1P receptor subtypes 5 (S1P5), S1P Receptor, sphingosine 1-phosphate (S1P)
Field of Research
Pharmacology & Drug Discovery
Purity
98.68% (May vary between batches)
Solubility
Ethanol:10 mg/mL (24.72 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.94 mM) ; DMSO:41.67 mg/mL (103.03 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
CC (C) Oc1ccc (cc1C#N) -c1nc (no1) -c1cccc2[C@H] (CCc12) NCCO
Molecular Formula
C23H24N4O3
Molecular Weight
404.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog